This Week in BMC Cancer

Premium

In BMC Cancer this week, researchers in Taiwan say that both isoforms of the Tazarotene-induced gene 1 tumor supressor gene supress cell growth in human colon cancer cell lines. Although the B isoform of TIG1 is known to inhibit growth and invasion of cancer cells, not much is known about the A isoform, the researchers write. In this study, the team found that both TGI1 isoforms are expressed at high levels in normal prostate tissue, and are downregulated in colon cancer cell lines.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.